• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

PLoS Comput Biol . Binding mechanism of oseltamivir and influenza neuraminidase suggests perspectives for the design of new anti-influenza drugs

tetano

Editor, Senior Moderator
PLoS Comput Biol


. 2022 Jul 28;18(7):e1010343.
doi: 10.1371/journal.pcbi.1010343. Online ahead of print.
Binding mechanism of oseltamivir and influenza neuraminidase suggests perspectives for the design of new anti-influenza drugs


Jiaye Tao[SUP] 1 [/SUP], Heping Wang[SUP] 2 [/SUP], Wenjian Wang[SUP] 2 [/SUP], Na Mi[SUP] 1 [/SUP], Wei Zhang[SUP] 1 [/SUP], Qiujia Wen[SUP] 1 [/SUP], Jiajing Ouyang[SUP] 1 [/SUP], Xinyun Liang[SUP] 1 [/SUP], Min Chen[SUP] 1 [/SUP], Wentao Guo[SUP] 1 [/SUP], Guoming Li[SUP] 1 [/SUP], Jun Liu[SUP] 1 [/SUP], Hanning Zhao[SUP] 1 [/SUP], Xin Wang[SUP] 1 [/SUP], Xuemeng Li[SUP] 1 [/SUP], Shengjun Feng[SUP] 1 [/SUP], Xinguang Liu[SUP] 3 [/SUP], Zhiwei He[SUP] 4 [/SUP], Zuguo Zhao[SUP] 1 [/SUP]



Affiliations

Abstract

Oseltamivir is a widely used influenza virus neuraminidase (NA) inhibitor that prevents the release of new virus particles from host cells. However, oseltamivir-resistant strains have emerged, but effective drugs against them have not yet been developed. Elucidating the binding mechanisms between NA and oseltamivir may provide valuable information for the design of new drugs against NA mutants resistant to oseltamivir. Here, we conducted large-scale (353.4 μs) free-binding molecular dynamics simulations, together with a Markov State Model and an importance-sampling algorithm, to reveal the binding process of oseltamivir and NA. Ten metastable states and five major binding pathways were identified that validated and complemented previously discovered binding pathways, including the hypothesis that oseltamivir can be transferred from the secondary sialic acid binding site to the catalytic site. The discovery of multiple new metastable states, especially the stable bound state containing a water-mediated hydrogen bond between Arg118 and oseltamivir, may provide new insights into the improvement of NA inhibitors. We anticipated the findings presented here will facilitate the development of drugs capable of combating NA mutations.
 
Back
Top Bottom